标普道琼斯指数公司宣布，将对标普小盘600指数（S&P SmallCap 600）的成分股进行调整。根据其声明，Solaris Energy Infrastructure, Inc.将取代Catalyst Pharmaceuticals在该指数中的位置。
此次调整旨在确保指数能够持续反映美国小盘股市场的代表性表现。Solaris Energy Infrastructure, Inc.的加入与Catalyst Pharmaceuticals的剔除，预计将在指数下一次定期调整时生效。
标普道琼斯指数公司宣布，将对标普小盘600指数（S&P SmallCap 600）的成分股进行调整。根据其声明，Solaris Energy Infrastructure, Inc.将取代Catalyst Pharmaceuticals在该指数中的位置。
此次调整旨在确保指数能够持续反映美国小盘股市场的代表性表现。Solaris Energy Infrastructure, Inc.的加入与Catalyst Pharmaceuticals的剔除，预计将在指数下一次定期调整时生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.